Correlation between left ventricular mass ındex and calcium metabolism in patients with essential hypertension

Objective: To determine the correlation between left ventricular mass index and calcium metabolism in patients with essential hypertension. Study Design: Cross sectional case-control study. Material and Methods: Twenty-seven patients with essential hypertension and 20 healthy individuals were compared with respect to calciotropic hormones, left ventricular mass index (LVMI), and urinary and serum biochemical parameters. The correlations between parathormone, vitamin D, and calcitonin levels and LVMI and blood pressure elevation were determined. Results: The parathormone level was significantly higher (p=0.006) and vitamin D level was significantly lower (p=0.01) in the patient group com- pared with the control group. However, the two groups were similar in terms of albumin-corrected calcium levels, which were within the normal range (p=0.988). The serum sodium (p=0.014) and urinary calcium (p=0.003) levels and LVMI (p

PDF

___

1. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992;117:831-6.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prog- nostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6. [CrossRef]
3. Pearson AC, Pasierski T, Labovitz AJ. Left ventricular hypertrophy:diagnosis, prognosis, and management. Am Heart J 1991;121:148-57. [CrossRef]
4. Duprez D, Bauwens F, De Buyzere M, De Backer T, Kaufman JM, Van Hoecke J, et al. Relationship between parathyroid hormone and left ventricular mass in moderate essential hypertension. J Hypertens Suppl 1991;9:116-7. [CrossRef]
5. Levy D. Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs 1988;35:1-5. [CrossRef]
6. Onat A, Sansoy V, Yıldırım B, Keleş İ, Çetinkaya A, Aksu H, et al. Investigations blood pressure levels in turkish adults: 8-year trends, rate of treatment, relationship to other risk factors and to coronary disease Türk Kardiyol Dern Arş 1999;27:136-43.
7. Messerli FH. Clinical determinants and consequences of left ven- tricular hypertrophy. Am J Med 1983;75:51-6. [CrossRef]
8. Kaplan NM, Lieberman E. Clinical hypertension. 7th ed. Williams & Wilkins, Baltimore;1998:281-99.
9. Bauwens FR, Duprez DA, De Buyzere ML, De Backer TL, Kaufman JM, Van Hoecke, J, et al. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moder- ate essential hypertension. Am J Cardiol 1991;68:925-9. [CrossRef]
10. Frohlich ED. Left ventricular hypertrophy, cardiac diseas- es and hypertension:recent experiences. J Am Coll Cardiol 1989;14:1587-94. [CrossRef]
11. Brickman AS, Nyby MD, von Hungen K, Eggena P, Tuck ML. Cal- citropic hormones, platelet calcium, and blood pressure in essen- tial hypertension. Hypertension 1990;16:515-22. [CrossRef]
12. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesa- rio F, et al. Left ventricular hypertrophy in primary hyperparathy- roidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999;50:321-8. [CrossRef]
13. Dominiczak AF, Lyall F, Morton JJ, Dargie HJ, Boyle IT, Tune TT, et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci (Lond) 1990;78:127-32.
14. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Ber- gler-Klein J, et al. Cardiac abnormalities in patients with primary hyperparathyroidism:implications for follow-up. J Clin Endocrinol Metab 1997;82:106-12. [CrossRef]
15. Morfis L, Smerdely P, Howes LG. Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J Hypertens 1997;15:1271-6. [CrossRef]
16. Marban E, Koretsune Y. Cell calcium, oncogenes, and hypertro- phy. Hypertension 1990;15:652-8. [CrossRef]
17. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46. [CrossRef]
18. Foppa M, Duncan BB, Rohde LL. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound 2005;17:3-17.
19. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;317:1098. [CrossRef]
20. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Mo- litch M, Krutzik S. Enhanced parathyroid function in essential hypertension:a homeostatic response to a urinary calcium leak. Hypertension 1980;2:162-8. [CrossRef]
21. Grobbee DE, Burger H, Hofman A, Pols HA. Blood pressure and bone density are inversely related in the elderly. J Hypertens 1996;14:35.
22. Resnick LM, Müller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649-54.
23. Young EW, Morris CD, McCarron DA. Urinary calcium excretion in essential hypertension. J Lab Clin Med 1992;120:624-32.
24. Kristal-Boneh E, Froom P, Harari G, Ribak J. Association of cal- citriol and blood pressure in normotensive men. Hypertension 1997;30:1289-94. [CrossRef]
25. Gennari C, Nami R, Bianchini C, Pavese G, Lucani B, Perrone AF. Renal excretion of calcium in human hypertension. Am J Nephrol 1986;6:124-7. [CrossRef] 26. Sowers JR, Zemel MB, Standley PR, Zemel PC. Calcium and hy- pertension. J Lab Clin Med 1989;114:338-48.
27. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hor- mone levels, vitamin D sufficiency, and calcium intake. JAMA 2005;294:2336-41. [CrossRef]
28. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF. An in- ternational comparison of serum 25- hydroxyvitamin D measure- ments. Osteoporos Int 1999;9:394-7. [CrossRef]
29. Savage DD, Drayer JI, Henry WL, Mathews EC Jr, Ware JH, Gardin JM, et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979:59:623-32. [CrossRef]
30. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Niederle B. Time course of regression of left ventricular hypertrophy after success- ful parathyroidectomy. Surgery 1997;121:157-61. [CrossRef]
31. Schlüter KD, Piper HM. Left ventricular hypertrophy and para- thyroid hormone:a causal connection? Cardiovascular Res 1998;37:34-41. [CrossRef]
32. Halapas A, Diamanti-Kondarakis E, Kremastinos D, Koutsil- leris M. The PTHrP/PTH.1-R bioregulation system in car- diac hypertrophy:possible therapeutic implications. In vivo 2006;20:837-44.
33. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism:incidence of cardiac abnormalities and partial reversibility after successful parathy- roidectomy. Am J Med 1993;95:197-202. [CrossRef]